The introduction of Ibrance has improved the prognosis for many patients with advanced breast cancer. Clinical trials have shown that it can significantly extend progression-free survival, meaning the time during which the cancer does not get worse. However, individual outcomes can vary, and it is important to have ongoing discussions with your oncologist to understand the expected benefits and risks.
